Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancer.
Saved in:
| Title: | Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancer. |
|---|---|
| Authors: | Higa K; Department of Urology, Kimitsu Chuo Byoin, Japan., Yamamoto S; Department of Urology, Kimitsu Chuo Byoin, Japan. Electronic address: satoshi.ym0809@gmail.com., Kurokawa K; Department of Urology, Kimitsu Chuo Byoin, Japan., Watanabe K; Department of Urology, Chibashiritu Aoba Byoin, Japan., Bamba H; Department of Urology, Kimitsu Chuo Byoin, Japan., Kanaoka S; Department of Urology, Kimitsu Chuo Byoin, Japan., Nakamura K; Department of Urology, Kimitsu Chuo Byoin, Japan. |
| Source: | Cancer genetics [Cancer Genet] 2025 Sep; Vol. 296-297, pp. 41-44. Date of Electronic Publication: 2025 Jun 10. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101539150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7762 (Print) NLM ISO Abbreviation: Cancer Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
